![Edward Basile](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edward Basile
Direktor/Vorstandsmitglied bei
TRANSMEDICS GROUP, INC.
Vermögen: 388 954 $ am 31.05.2026
Profil
Edward M.
Basile is currently Director at TransMedics, Inc., Independent Director at TransMedics Group, Inc. since 2016, and Member of The Food & Drug Law Institute.
Former positions include Chairman-FDA & Life Sciences Practice at King & Spalding LLP, Associate Chief Counsel at the US Food & Drug Administration from 1975 to 1985, and Principal at Advanced Medical Technology Association.
Education includes graduate studies completed in 1972 at George Washington University and undergraduate studies completed in 1969 at Lafayette College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TRANSMEDICS GROUP, INC. 0,02 % | 20.05.2026 | 5.788 ( 0,02 % ) | 388 954 $ | 31.05.2026 |
Aktive Positionen von Edward Basile
| Unternehmen | Position | Beginn |
|---|---|---|
| TRANSMEDICS GROUP, INC. | Direktor/Vorstandsmitglied | 01.02.2016 |
The Food & Drug Law Institute
 The Food & Drug Law Institute Miscellaneous Commercial ServicesCommercial Services Operates as a food and drug law institute | Corporate Officer/Principal | - |
TransMedics, Inc.
 TransMedics, Inc. Medical SpecialtiesHealth Technology Manufactures and develops medical devices | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Edward Basile
| Unternehmen | Position | Ende |
|---|---|---|
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | 01.01.1985 |
Advanced Medical Technology Association
 Advanced Medical Technology Association Miscellaneous Commercial ServicesCommercial Services Operates as a trade association that offers information on philanthropy, blood products, diagnostics, orthopedics, ophthalmic, wound care and disaster preparedness | Corporate Officer/Principal | - |
King & Spalding LLP
 King & Spalding LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Ausbildung von Edward Basile
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
92
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
George Washington University
 George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
King & Spalding LLP
King & Spalding LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Lafayette College
 Lafayette College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransMedics, Inc.
TransMedics, Inc. Medical SpecialtiesHealth Technology Manufactures and develops medical devices | Health Technology |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Advanced Medical Technology Association
Advanced Medical Technology Association Miscellaneous Commercial ServicesCommercial Services Operates as a trade association that offers information on philanthropy, blood products, diagnostics, orthopedics, ophthalmic, wound care and disaster preparedness | Commercial Services |
The Food & Drug Law Institute
The Food & Drug Law Institute Miscellaneous Commercial ServicesCommercial Services Operates as a food and drug law institute | Commercial Services |
TransMedics Group, Inc.
 TransMedics Group, Inc. Medical SpecialtiesHealth Technology Manufactures portable electromechanical medical devices for organ transplantation of end-stage organ failure patients | Health Technology |
